Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for tirzepatide in people with overweight/obesity and chronic kidney disease, with or without Type 2 diabetes, currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING